|
Bio-Techne corporation
nb100-79931 Nb100 79931, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/79931/bio-techne+corporation___nb100-79931?v=Bio-Techne+corporation Average 90 stars, based on 1 article reviews
nb100-79931 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BPS Bioscience
sars cov 2 spike ace2 ![]() Sars Cov 2 Spike Ace2, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/79931/pmc08646260-143-17-21?v=BPS+Bioscience Average 93 stars, based on 1 article reviews
sars cov 2 spike ace2 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
AMS Biotechnology
spike s1 rbd (sars-cov-2): ace2 inhibitor screening assay kit ![]() Spike S1 Rbd (Sars Cov 2): Ace2 Inhibitor Screening Assay Kit, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/79931/custom%4079931%4034585460?v=AMS+Biotechnology Average 93 stars, based on 1 article reviews
spike s1 rbd (sars-cov-2): ace2 inhibitor screening assay kit - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Standard format: Plasmid sent in bacteria as agar stab
|
Buy from Supplier |
Image Search Results
Journal: Molecular Informatics
Article Title: Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combined in silico and in vitro Study
doi: 10.1002/minf.202100062
Figure Lengend Snippet: Box and Whisker plot representation of MM/GBSA scores of selected hit compounds at the SARS‐CoV‐2 Main Protease target. In the plots, central line in box represents median, bottom line of box is first quartile (25 %), top line of box is third quartile (75 %), bottom of whiskers is first quarter minus 1.5× interquartile range, top of whiskers is third quarter plus 1.5× interquartile range, and dots are outliers.
Article Snippet: Two different inhibitor screening assay kits against Spike protein were used as ACE2:SARS‐CoV‐2 Spike S1 (#79945) and
Techniques: Whisker Assay
Journal: Molecular Informatics
Article Title: Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combined in silico and in vitro Study
doi: 10.1002/minf.202100062
Figure Lengend Snippet: Box and Whisker plot representation of MM/GBSA scores of selected hit compounds at the SARS‐CoV‐2 Spike/ACE2 target. In the plots, central line in box represrents median, bottom line of box is first quartile (25 %), top line of box is third quartile (75 %), bottom of whiskers is first quarter minus 1.5× interquartile range, top of whiskers is third quarter plus 1.5× interquartile range, and dots are outliers.
Article Snippet: Two different inhibitor screening assay kits against Spike protein were used as ACE2:SARS‐CoV‐2 Spike S1 (#79945) and
Techniques: Whisker Assay
Journal: Molecular Informatics
Article Title: Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combined in silico and in vitro Study
doi: 10.1002/minf.202100062
Figure Lengend Snippet: Change in SARS‐CoV‐2 Spike/ACE2 binding with different inhibitor concentrations. The compound was tested at least with four replicates. Mean and standard deviation results were provided at the figure.
Article Snippet: Two different inhibitor screening assay kits against Spike protein were used as ACE2:SARS‐CoV‐2 Spike S1 (#79945) and
Techniques: Binding Assay, Standard Deviation